Lombard Odier Asset Management (USA)’s Celularity CELU Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,000	Closed	-$406K	–	377
2022 Q1	$436K	Sell	5,000 -1,000	-17%	-$59.9K	0.02%	215
2021 Q4	$307K	Buy	6,000 +2,000	+50%	+$128K	0.01%	274
2021 Q3	$283K	Buy	+4,000	New	+$323K	0.01%	273
2021 Q2	–	Sell	-40,000	Closed	-$4.03M	–	307
2021 Q1	$4.03M	Buy	+40,000	New	+$4.1M	0.15%	79

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LDFO

Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s CELU Position: Q2 2022 in Review

Lombard Odier Asset Management (USA) sold out of Celularity (CELU) in Q2 2022, closing a stake of 5,000 shares — an estimated $406K sold.

Lombard Odier Asset Management (USA) first reported a position in CELU in Q1 2021 and held it in 4 quarters. The position peaked at $4.03M in Q1 2021. 66 funds tracked by Wall St. Rank hold CELU as of Q2 2022.

Lombard Odier Asset Management (USA) reported no remaining Celularity position as of Q2 2022 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 5,000 Celularity shares in Q2 2022, an estimated $406K.
Lombard Odier Asset Management (USA) first reported a position in Celularity in Q1 2021 and held it in 4 quarters.
Lombard Odier Asset Management (USA)'s Celularity position peaked at $4.03M in Q1 2021.
66 funds tracked by Wall St. Rank held Celularity as of Q2 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2022, filed 15 Aug 2022.